Why the Volpara Health Technologies Ltd share price is rocketing today

Can the Volpara Health Technologies Ltd (ASX:VHT) share price do a Pro Medicus Limtied (ASX:PME)?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Volpara Health Technologies Ltd (ASX: VHT) share price is on the move again today after the developer of sophisticated breast cancer screening software technology had an 87 cents price target slapped on it by capital markets work seeker and investment research house Morgans.

In response the Volpara share price has climbed 10% or 5 cents to 55 cents this afternoon, although it has previously struck highs of 87 cents back in November 2016.

The New Zealand-headquartered group is attempting to sell its software-as-service (SaaS) technology to oncology departments worldwide and as a result of recent investments in the technology and additional sales staff its net loss ballooned to NZ$4.675 million for the half-year period ending December 31 2016, compared to NZ$2.06 million in the prior corresponding half.

The bright side of the recent result is that sales revenues grew to NZ$1.19 million, with a cash balance of NZ$6.795 million. As at March 3 2017 total contract value for deals signed so far in FY 2017 stood at NZ$3.44 million, with the company's SaaS model meaning revenue is delivered over the life of a contract, with revenue even delivered for every woman screened using the Volpara technology.

In this sense Volpara is quite similar to ASX small-cap medical imaging and SaaS wonder stock Pro Medicus Limtied (ASX: PME). Thanks to its recent success in U.S. hospital and healthcare provider markets Pro Medicus has grown into a market value around $462 million in recent years.

Volpara then appears to have a lot of potential, but as a loss maker with minimum sales it remains speculative and the kind of business suitable only for experienced investors prepared to stomach volatile share prices.

Motley Fool contributor Tom Richardson has no position in any stocks mentioned. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »